Indian Institute of Technology (IIT) Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV drug, has shown potential in reducing ...

The research suggests that Efavirenz, a drug commonly used to treat HIV, may help reduce the replication of the Chikungunya virus. With promising results observed in both laboratory settings and ...

As per the findings, Efavirenz, a drug widely used for HIV treatment, may serve as an effective therapy for Chikungunya disease, as it has been shown to reduce Chikungunya virus replication both ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...